Chapter 8: Enzymes as Catalysts

Welcome to Last Minute Lecture.

This free chapter overview is designed to help students review and understand key concepts.

These summaries supplement not replaced the original textbook and may not be redistributed or resold.

For complete coverage, always consult the official text.

Welcome back to the Deep Dive.

Today, we're really getting into the microscopic machinery of life itself.

We're talking about enzymes.

That's right.

Those incredible molecular machines that, basically, make everything happen in our bodies.

Our roadmap for this journey is Chapter 8, Enzymes as Catalysts, from Mark's Basic Medical Biochemistry, a clinical approach.

Yep.

Our goal here is really to give you, our listener, a clear path through this.

Understanding enzymes is just so fundamental.

It really is.

It's not just for biochem students.

It's for anyone curious about how we work fundamentally and how we find ways to fix things when they go wrong, like with new drugs.

Exactly.

So enzymes, think of them as the body's ultimate speed boosters, mostly proteins acting as catalysts.

And when you say speed boosters, you're not kidding, are you?

The numbers are staggering.

Oh, absolutely staggering.

We're talking speeding reactions up by like a million times, maybe even up to a hundred trillion times faster.

It's almost hard to comprehend.

Wow.

And it's not just about speed, is it?

There's more to it.

Definitely not just speed.

Specificity is huge.

And regulation.

They control entire metabolic pathways, making sure the right things happen at the right time, without them.

Right.

Well, life as we know wouldn't exist.

Reactions would just be too slow.

Okay.

So how do they actually do it?

What's the basic process?

It seems like a bit of a dance.

It is.

Yeah.

You could call it a three -step dance.

First, the enzyme, let's call it E, binds to its specific reactant molecule, the substrate S.

So E plus S, they connect.

Right.

They reversibly form this complex, the enzyme substrate complex, or ES.

That's step one.

Okay.

Step one, binding.

What's next?

Step two is the transformation.

Inside that complex, the enzyme works its magic, and the substrate S gets converted into the product P.

So now we have an enzyme product complex, EP.

ES becomes EP.

Got it.

And the final step.

Product release.

Yeah.

The enzyme lets go of the product P, but EP becomes E plus P.

And the crucial part, the enzyme E is back to its original state, totally unchanged, ready for the next substrate molecule.

Like a tireless worker on an assembly line, never used up.

Exactly.

Regenerated every single time.

Okay.

That's a cycle.

But let's zoom in.

Where does this transformation actually happen on the enzyme?

That happens at a very special place called the active catalytic site,

or just the active site.

The active site.

Like a little pocket or groove.

Precisely.

It's a specific cleft or crevice in the enzyme's 3D structure.

It's formed by specific amino acid residues, and it's perfectly shaped to bind the substrate and carry out the chemistry.

And that shape, that structure, is key to their specificity, right?

They don't just grab anything.

Not at all.

That precise 3D arrangement of amino acids makes each enzyme incredibly selective.

It only binds its specific substrate, or maybe a small group of very similar ones.

It ensures chemical order instead of chaos.

I remember learning about models for how this binding works.

The old idea was lock and key.

Yeah, the lock and key model was the initial concept, proposed by Emil Fischer way back.

It suggested a rigid enzyme and a rigid substrate fitting together perfectly, like a key in its lock.

Simple, but maybe too simple.

Well, it's a good start, but yeah, we now have a more refined view.

The induced fit model.

Ah, induced fit.

That sounds more dynamic.

It is.

Think of it more like a hand fitting into a glove.

The enzyme isn't totally rigid.

When the substrate binds, the enzyme can actually change its shape slightly.

It molds around the substrate.

Exactly.

This conformational change can improve the binding, position the catalytic groups just right, or even help activate the substrate.

Is there a good example of that?

Oh, absolutely.

Glucocannese is a great one.

When glucose binds, the enzyme literally closes a cleft around it.

This does two things.

It helps position ATP, the other substrate, correctly, and it kicks out water molecules that can interfere with your reaction.

It's really elegant.

Wow.

Okay.

So the enzyme actively participates in getting the fit just right.

But how does this all lead to speeding things up?

You mentioned that huge speed increase.

It must involve energy.

It absolutely does.

It's all about overcoming an energy barrier.

Every chemical reaction needs a certain amount of energy to get started.

That's the activation energy.

Like pushing a boulder up a hill before it can roll down the other side.

That's a perfect analogy.

And at the very top of that energy hill, there's this unstable high -energy intermediate state called the transition state complex.

It's fleeting.

Very unstable.

So the higher the hill, the slower the reaction.

How do enzymes help?

They lower the hill.

Enzymes work by stabilizing that unstable transition state complex.

By stabilizing it.

How?

They're designed to bind most tightly to that transition state, much tighter than they bind to the substrate or the product.

By cradling and stabilizing this high -energy intermediate,

they dramatically lower the activation energy needed to reach it.

So they don't change the start or end points, just make the path between them easier?

Precisely.

The overall energy change of the reaction remains the same, but the barrier to get there is significantly reduced, making the reaction happen much, much faster.

And stabilizing that transition state, that sounds like something drug designers would be very interested in.

Oh, hugely interested.

It's a core principle.

If you can design a molecule that looks like the transition state analog, it will bind incredibly tightly to the enzyme.

Because the enzyme is evolved to bind that state tightly anyway.

Exactly.

So the analogs are often extremely potent, specific enzyme inhibitors.

It's a major strategy in drug development.

And I think the source mentioned something about artificial enzymes too.

Abzymes.

Yes, abzymes.

Yeah.

Catalytic antibodies.

It's fascinating stuff.

Scientists can actually raise antibodies against transition state analogs.

These antibodies then sometimes gain the ability to catalyze the reaction themselves.

Or like in the cocaine esterase example, catalyze the breakdown of a target molecule.

It's like building enzymes to order.

Incredible.

Okay.

So enzymes lower the energy barrier, but how?

What are the actual chemical tricks they use?

They're strategies.

Right.

They have a toolkit of strategies.

The chapter outlines five main ones.

First up is acid -base catalysis.

Acid base.

Yeah.

Like donating or accepting protons.

Exactly.

Amino acid side chains in the active site can act as proton donors, acids, or acceptors bases to help the reaction along.

Chymotrypsin, a digestive enzyme, uses a histidine residue for this, shuttling protons back and forth.

But what about enzymes in extreme environments, like pepsin in the stomach?

The pH is super low Great point.

Histidine wouldn't work wide as a base at that very low pH.

It would already be protonated.

So pepsin uses aspartate residues instead.

They have a different picaea, allowing them to still function effectively, often by activating a water molecule, even in that highly acidic environment.

It shows how enzymes are adapted.

Clever adaptation.

Strategy number two.

Covalent catalysis.

Here, the enzyme actually forms a temporary covalent bond with the substrate during the reaction process.

A temporary bond, like it hooks onto it for a bit.

Yeah.

A good example, again, is chymotrypsin.

A serine residue in its active site forms a transient covalent bond and a sile enzyme intermediate, which helps break the peptide bond in the protein being digested.

Okay.

Covalent bonds.

What's next?

Metals.

Yep.

Metal ion catalysis.

Many enzymes need metal ions, like zinc, magnesium, iron, to work.

These ions can help in several ways.

They can help orient the substrate correctly.

They can stabilize negative charges that form during the reaction, or they can even directly participate in electron transfer, like in redox reactions.

Think of zinc in carbonic anhydrase, helping position a water molecule.

So metals are like little helpers in the active site.

Strategy four.

Catalysis by approximation.

This was pretty intuitive, actually.

Approximation.

Getting things close together.

Exactly.

Enzymes bind their substrates in just the right orientation and proximity to each other.

Imagine trying to get two specific Lego bricks to click together randomly in a big box, versus holding them perfectly aligned.

The enzyme does the holding.

Makes the reaction much more likely to happen, like nucleoside monophosphate kinases.

Precisely.

They bring the nucleotide and ATP together perfectly for the phosphate transfer.

And the fifth strategy.

Cofactor catalysis.

This involves non -protein helpers called cofactors, which we'll talk more about.

In this strategy, the cofactor itself often forms a temporary covalent bond with the substrate to facilitate the reaction.

Paradoxal phosphate in amino acid reactions is a key example.

Okay, you've mentioned cofactors a couple of times now, these non -protein helpers.

They seem really important, providing chemistry that maybe amino acids alone can't handle.

They are absolutely essential for many enzymes.

Cofactors provide functional groups or capabilities beyond the standard 20 amino acid side chains.

They fall into categories.

Coenzymes, which are organic molecules, often derive from vitamins.

Ah, the vitamin connection.

Right.

And metal ions, which we just discussed.

Sometimes you have metallocoenzymes, which are complexes.

But here's a key thing.

Why do coenzymes, these often complex molecules, have so little activity on their own?

Yeah, that's interesting.

If they have the reactive part, why do they need the enzyme?

Because the enzyme provides the context.

Think proximity, orientation, activation.

The chance of a substrate and a free coenzyme bumping into each other just right in solution is tiny.

The enzyme binds both, holds them perfectly, and often even activates the coenzyme, maybe by tweaking its chemical environment.

So the enzyme is the stage manager, making sure everyone hits their marks.

Perfectly put.

Let's look at some key activation transfer coenzymes.

Thiamine pyrophosphate, TPP, from vitamin thiamine.

It needs magnesium, often, and it forms covalent bonds to help break CC bonds.

Crucial in carbohydrate metabolism.

Okay.

TPP from thiamine.

What else?

Coenzyme A, CoA, derived from pantothenate.

It has this reactive sulfhydryl group that attacks carbonyl groups, forming acyl thioesters.

Really important for carrying acyl groups, like in the citric acid cycle, it gets regenerated afterwards.

Bill A, right.

And biotin.

It's usually covalently attached to its enzyme, often via a lysine residue.

It's the master of carrying activated carbon dioxide for carboxylation reactions.

And paradoxyl phosphate, PLP, you mentioned it before.

Yes, PLP from vitamin B6, forms covalent bonds with amino groups.

It's incredibly versatile, involved in all sorts of amino acid transformations, transamination, decarboxylation, you name it.

So these activation transfer coenzymes, they seem to share some features.

They do.

Generally, they have a part that binds specifically to the enzyme, a separate functional group that actually does the chemistry,

and they rely heavily on the enzyme for both specificity and catalytic power.

Now this talk of vitamin -derived cofactors, it makes me think of the case study Al M, the man with chronic alcoholism.

There's a direct link there, isn't there?

A very tragic and direct link.

Chronic alcoholism can severely impair the absorption of thiamine from the gut.

No thiamine means no TPP.

And enzymes needing TPT just stop working properly.

Exactly.

Key metabolic pathways, especially in carbohydrate metabolism, start to fail.

On top of that, alcohol metabolism produces acetaldehyde, which is toxic.

It can actually kick PLP off its enzymes and lead to its degradation, so you get multiple cofactor deficiencies.

Which leads to the symptoms described.

Berry -berry heart disease, neurological problem.

Precisely.

Because the underlying enzyme activities are crippled, it really underscores how vital these vitamin -derived cofactors are for basic cellular function.

A stark reminder.

Okay, besides activation transfer, you also mention oxidation reduction coenzymes?

Right.

These guys handle electron transfer.

Gaining or losing electrons, often in the form of hydrogen atoms or hydride ions.

Like NAD plus eta.

NAD plus eta.

Nicotinamide adenine dinucleotide, derived from niacin, is the classic example.

It accepts a hydride ion that's a proton plus two electrons, becoming NADH.

Crucial in pathways like glycolysis and the citric acid cycle.

Lactate dehydrogenase, oxidizing lactate to pyruvate, uses NAD plus eta.

And the enzyme helps NAD plus do its job.

Oh yeah.

The enzyme often helps abstract a proton, making it easier for the hydride transfer to NAD plus to occur.

FAD is another important one.

And even antioxidants like vitamin E and vitamin C function as redox cofactors in certain contexts.

And metal ions pop up again here too.

They do.

Their positive charge makes them great electron attractors, electophiles.

They can bind substrates, stabilize negative charges that might form during a reaction, and directly participate in redox reactions.

Magnesium helping bind ATP phosphates, zinc stabilizing charge in alcohol, dehydrogenase.

They're versatile players.

Okay, so enzymes have their strategies, their cofactors.

But they're also sensitive, right, to their surroundings.

Like pH and temperature.

Very sensitive.

There's definitely a Goldilocks zone for optimal activity.

Take pH.

Changes in pH affect the ionization state of amino acid side chains, especially those in the active site.

So if the charge changes, the catalysis might not work, or the enzyme might even change shape.

Exactly.

Activity typically rises to an optimum pH, usually around physiological pH 7 .4 for most human enzymes, but different for, say, stomach enzymes, and then drops off sharply on either side as key groups lose their optimal charge or the enzyme structure gets disrupted.

And temperature.

We know high fevers are bad.

Right.

Increasing temperature initially speeds up reactions, more kinetic energy, more collisions.

But for human enzymes, go much above the optimal 37 degrees C, and things go downhill fast.

Denaturation.

The heat energy disrupts the weak bonds holding the enzyme's specific 3D shape together.

It unfolds, loses its active site structure, and loses activity, often irreversibly.

That's why prolonged high fever is so dangerous.

Widespread enzyme failure.

Makes sense.

Okay, we've covered how enzymes work.

Now what about stopping them?

Inhibitors.

Hugely important for medicine, but also sources of toxicity.

Absolutely crucial topic.

Inhibitors decrease enzyme activity.

Many are mechanism -based, meaning they interact with the enzyme based on its catalytic mechanism, often mimicking substrates or intermediates.

And some are pretty permanent, forming strong bonds.

Yes, those are covalent inhibitors.

They form stable, often irreversible, covalent bonds with reactive functional groups in the active site, effectively killing the enzyme molecule.

These active site groups are often especially reactive, making them targets.

Like in the case of Dennis V and the malathion poisoning.

Exactly.

Malathion itself isn't the main culprit.

It gets converted in the liver to malaxon.

That's the potent covalent inhibitor.

And it targets acetylcholinesterase.

Yes, the enzyme that breaks down the neurotransmitter acetylcholine.

Malaxon forms a covalent bond with a key serine in the active site.

Acetylcholine builds up over -stimulating nerves, causing all those symptoms, vomiting, cramps, salivation, muscle twitching.

And the treatment involves blocking acetylcholine and trying to break that covalent bond.

Right.

Atropine blocks the acetylcholine receptors, and pralidoxime can, if given early enough,

reactivate the enzyme by displacing the inhibitor.

Aspirin is another common example.

It covalently acetylates a serine in cyclooxygenase.

So covalent inhibition can be bad, but also therapeutic.

What about those transition state analogs you mentioned earlier?

Transition state analogs are incredibly effective because, as we said, enzymes bind the transition state super tightly.

So these mimics are potent, often highly specific inhibitors.

Penicillin is the classic example here, right?

The suicide inhibitor.

It is.

Penicillin is amazing.

It looks enough like the natural substrate for the bacterial enzyme

transferase, which builds cell walls, that the enzyme starts to react with it.

But it gets stuck.

It gets stuck.

The enzyme forms a covalent bond with penicillin, but the reaction can't complete.

The penicillin remains attached, permanently inactivating the enzyme.

It's called suicide inhibition because the enzyme participates in its own inactivation.

And crucially, we don't have that enzyme, so it's specific to bacteria.

Brilliant.

And allopurinol for gout, in Lottetie's case, also suicide inhibition.

Yes, and another great example.

Gout involves excess uric acid.

Xanthine oxidase is the enzyme that makes uric acid.

Allopurinol is actually a substrate for xanthine oxidase.

Oh, so the enzyme acts on it.

It oxidizes allopurinol to oxypurinol.

But then, this product, oxypurinol, binds extremely tightly, essentially irreversibly, back into the active site of xanthine oxidase, shutting it down.

No more uric acid production.

Clever.

Very clever.

Lastly, what about things like heavy metals?

They inhibit enzymes too, but differently.

Heavy metals like mercury and lead tend to be much less specific inhibitors.

Mercury loves to bind to sulfhydryl -type groups on cysteine residues, which are often important for enzyme structure or activity.

This can mess up lots of different enzymes.

And lead.

Lead can be nasty because it can mimic and replace essential metal ions like calcium or zinc and enzymes and regulatory proteins, disrupting their function.

Think developmental problems, neurological issues, it's interfering at a fundamental biochemical level.

Okay, this is a huge amount of detail about different enzymes and inhibitors.

Is there a system for keeping track of them all?

Thankfully, yes.

The Enzyme Commission, EC, developed a classification system.

It groups enzymes into six major classes based purely on the type of reaction they catalyze.

It provides a logical framework.

Each enzyme gets a unique four -part EC number.

Six classes based on reaction type.

Can you quickly run through them?

Sure.

Class one, oxidoreductases.

Anything involving oxidation or reduction transfer of electrons or hydrogen.

Dehydrogenases, oxidases are examples.

Okay, class two.

Transferases.

They transfer a functional group, like a methyl group or a phosphate group, from one molecule to another.

Kinases, which transfer phosphate from ATP, are classic transferases.

Got it.

Class three.

Hydrolysis.

These break chemical bonds by adding water across the bond.

Think digestion proteases breaking peptide bonds.

Liposes breaking ester bonds and fats.

Hydrolysis breaking with water.

Class four.

Litases.

These break CC, CO, CN, or other bonds, but not by hydrolysis or oxidation.

They often form double bonds or rings.

Decarboxylases removing CO2 are lysis.

Different way of breaking bonds.

Class five.

Isomerases.

These just rearrange atoms within a single molecule, converting it into an isomer.

Mutases that shift a phosphate group around on a sugar are isomerases.

Rearranging the furniture, basically.

And finally, class six.

Legacies.

These enzymes join two molecules together, forming new CC, CS, CO, or CN bonds.

Crucially, this bond formation is coupled to the cleavage of ATP, which provides the energy.

Synthetases are legacies.

And you mentioned a distinction there.

Synthetases versus syntheses.

Right.

It's a common point of confusion.

Synthetases are legases.

They use ATP or another NTP.

Syntheses catalyze synthesis reactions too, but they don't directly use ATP hydrolysis for energy.

So class six are the ATP -dependent ones.

Okay.

That classification system definitely helps organize things.

Yeah.

We've covered a lot of ground today on enzymes.

We really have.

Just to quickly recap for you, the listener.

We saw that enzymes are incredibly powerful, highly specific protein catalysts.

They work via their active sites, using a range of catalytic strategies.

Acid base, covalent bonds, metal ions, approximation to lower activation energy by stabilizing that critical transition state.

And we can't forget their essential partners, the cofactors, often derived from vitamins like thiamine and B6.

Their deficiency, as seen in alcoholism, can have severe clinical consequences because key enzymes just can't function.

Exactly.

We also touched on how sensitive enzymes are to pH and temperature and how inhibitors work sometimes as dangerous toxins, like melathion's active form, meloxon, but often as incredibly useful drugs,

When you step back, it's amazing.

These tiny molecular machines underpin literally every process in our bodies, from thinking to moving to digesting, and understanding them is key to medicine.

It truly is.

They are central players in health and disease and major targets for therapeutic intervention.

So here's something to think about as we wrap up.

As our knowledge of enzyme structure, function, and mechanism gets ever deeper, how might we move beyond just inhibiting them?

Could we perhaps start reliably designing entirely new enzymes, maybe artificial ones, to perform specific tasks in the body or in biotechnology that natural enzymes don't?

What new therapies or tools might that unlock?

That's a fascinating thought for the future.

The potential is certainly there.

Thank you for joining us on this deep dive into the world of enzymes.

We hope it's given you a clearer picture of these vital molecules.

We're the Deep Dive team, wishing you the very best in your continued learning.